CytomX Therapeutics, Inc. — All Filings
762 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B3
424B4
424B5
5
8-A12B
8-K
8-K/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
EFFECT
PRE 14A
S-1
S-1/A
S-3
S-3/A
S-3ASR
S-8
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-001034 | Mar 26, 2026 | — |
| 4 | — | 0001610717-26-000125 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000124 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000123 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | — | 0001610717-26-000122 | Mar 19, 2026 | Mar 17, 2026 |
| 8-K | 8-K | 0001193125-26-115958 | Mar 19, 2026 | Mar 17, 2026 |
| 424B5 | 424B5 | 0001193125-26-113931 | Mar 18, 2026 | — |
| 424B5 | 424B5 | 0001193125-26-108461 | Mar 16, 2026 | — |
| S-3ASR | S-3ASR | 0001193125-26-108302 | Mar 16, 2026 | — |
| 8-K | 8-K | 0001193125-26-107152 | Mar 16, 2026 | — |
| 10-K | 10-K | 0001193125-26-107146 | Mar 16, 2026 | Dec 31, 2025 |
| SCHEDULE 13G | — | 0001907884-26-000006 | Mar 4, 2026 | — |
| SCHEDULE 13G/A | — | 0000947871-26-000190 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0001214659-26-002019 | Feb 17, 2026 | — |
| SCHEDULE 13G/A | — | 0000315066-26-000388 | Feb 5, 2026 | — |
| 4 | — | 0001610717-26-000043 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001610717-26-000042 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001610717-26-000041 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001610717-26-000040 | Feb 4, 2026 | Feb 2, 2026 |
| 4 | — | 0001610717-26-000039 | Feb 4, 2026 | Feb 2, 2026 |
| SCHEDULE 13G/A | — | 0001738048-25-000016 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-005005 | Nov 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001013594-25-001422 | Nov 14, 2025 | — |
| 4 | — | 0001610717-25-000372 | Nov 10, 2025 | Nov 6, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-002911 | Nov 7, 2025 | — |
| 144 | — | 0001628280-25-050396 | Nov 6, 2025 | — |
| 8-K | 8-K | 0001193125-25-269533 | Nov 6, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-269477 | Nov 6, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0000315066-25-002714 | Nov 5, 2025 | — |
| 4 | — | 0001610717-25-000370 | Oct 29, 2025 | Oct 20, 2025 |
| 3 | — | 0001610717-25-000369 | Oct 29, 2025 | Oct 20, 2025 |
| 4 | — | 0001610717-25-000357 | Sep 30, 2025 | Sep 26, 2025 |
| 4 | — | 0001610717-25-000356 | Sep 30, 2025 | Sep 26, 2025 |
| 4 | — | 0001610717-25-000355 | Sep 30, 2025 | Sep 26, 2025 |
| 4 | — | 0001610717-25-000354 | Sep 30, 2025 | Sep 26, 2025 |
| SCHEDULE 13G | — | 0000950170-25-110649 | Aug 21, 2025 | — |
| EFFECT | — | 9999999995-25-002666 | Aug 18, 2025 | — |
| SCHEDULE 13G | — | 0000947871-25-000782 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0000902664-25-003701 | Aug 14, 2025 | — |
| SCHEDULE 13G/A | — | 0001214659-25-012267 | Aug 14, 2025 | — |
| CORRESP | — | 0001193125-25-180756 | Aug 14, 2025 | — |
| UPLOAD | — | 0000000000-25-008499 | Aug 13, 2025 | — |
| 8-K | 8-K | 0001193125-25-179463 | Aug 13, 2025 | — |
| S-8 | S-8 | 0001193125-25-175473 | Aug 7, 2025 | — |
| S-3 | S-3 | 0001193125-25-175465 | Aug 7, 2025 | — |
| 8-K | 8-K | 0000950170-25-105053 | Aug 7, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-104991 | Aug 7, 2025 | Jun 30, 2025 |
| SCHEDULE 13G | — | 0000315066-25-001984 | Aug 6, 2025 | — |
| SCHEDULE 13G/A | — | 0000932471-25-000780 | Jul 29, 2025 | — |
| SCHEDULE 13G/A | — | 0000921895-25-001982 | Jul 9, 2025 | — |